Clinical utility of SARS-CoV-2 subgenomic RT-PCR in a pediatric quaternary care setting
•SARS-CoV-2 subgenomic RNA (sgRNA) intermediates can be detected by PCR.•The detection of SARS-CoV-2 sgRNA correlates with increased COVID-19 severity.•IPC teams use sgRNA PCR to inform isolation/de-isolation decisions.•sgRNA PCR CT values correlate with genomic RNA CT values, regardless of target....
Gespeichert in:
Veröffentlicht in: | Journal of clinical virology 2023-07, Vol.164, p.105494-105494, Article 105494 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | •SARS-CoV-2 subgenomic RNA (sgRNA) intermediates can be detected by PCR.•The detection of SARS-CoV-2 sgRNA correlates with increased COVID-19 severity.•IPC teams use sgRNA PCR to inform isolation/de-isolation decisions.•sgRNA PCR CT values correlate with genomic RNA CT values, regardless of target.
During active transcription, SARS-CoV-2 generates subgenomic regions of viral RNA. While standard SARS-CoV-2 RT-PCR amplifies region(s) of genomic RNA, it cannot distinguish active infection from remnant viral genomic material. However, screening for subgenomic RNA (sgRNA) by RT-PCR may aid in the determination of actively transcribing virus.
To evaluate the clinical utility of SARS-CoV-2 sgRNA RT-PCR testing in a pediatric population.
Retrospective analysis was performed on inpatients from February-September 2022 positive for SARS-CoV-2 by RT-PCR with a concomitant order for sgRNA RT-PCR. Chart abstractions were conducted to determine clinical outcomes, management, and infection prevention and control (IPC) practices.
Of 95 SARS-CoV-2 positive samples from 75 unique patients, 27 (28.4%) were positive by sgRNA RT-PCR. A negative sgRNA RT-PCR test allowed for de-isolation in 68 (71.6%) patient episodes. Regardless of age or sex, a positive sgRNA RT-PCR result significantly correlated with disease severity (P = 0.007), generalized COVID-19 symptoms (P = 0.012), hospitalization for COVID-19 (P = 0.019), and immune status (P = 0.024). Moreover, sgRNA RT-PCR results prompted changes in management in 28 patients (37.3%); specifically, therapeutic escalation in 13/27 (48.1%) positives and de-escalation in 15/68 (22.1%) negatives.
Taken together, these findings underscore the clinical utility of sgRNA RT-PCR testing in a pediatric population as we report significant associations between sgRNA RT-PCR results and clinical parameters related to COVID-19. These findings align with the proposed use of sgRNA RT-PCR testing to guide patient management and IPC practices in the hospital setting. |
---|---|
ISSN: | 1386-6532 1873-5967 |
DOI: | 10.1016/j.jcv.2023.105494 |